Hospital Admin Articles

Hospital Admin

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Genmab announced that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for Arzerra (ofatumumab) to treat patients whose chronic lymphocytic leukemia (CLL) is resistant (refractory) to previous therapies and has granted ofatumumab priority review status.


Today in Licensure/Accreditation...keeping you current

California licensing backlog keeping doctors from starting jobs
American Medical News , 11/10/09

The Joint Commission Introduces Perinatal Care Core Measures
Joint Commission news, 11/24/09

Models of consumer value cocreation in health care
Health Care Management Review, 11/05/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address